Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
/in International Publications, Newcastle Disease Virus /von 2012-05-29 / Appl. Biochem. Biotechnol. 2012 Aug;167(7):2005-22Cancer immunotherapy: a paradigm shift for prostate cancer treatment
/in Dendritic Cells, International Publications, Prostate Cancer /von 2012-05-29 / Nat Rev Urol 2012 May;9(7):376-85Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy
/in Dendritic Cells, Hyperthermia, International Publications, Ovarian Cancer /von 2012-05-05 / Case Rep Oncol 2012 May;5(2):212-5Current status of immunological approaches for the treatment of prostate cancer
/in International Publications, Prostate Cancer /von 2012-05-01 / Curr Opin Urol 2012 May;22(3):197-202Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
/in Colorectal Cancer, Hyperthermia, International Publications /von 2012-05-01 / J. Cell. Biochem. 2012 May;113(5):1547-58
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution